Gaudium IVF And Women Health Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 ,inter alia, to consider and approve the Un-audited ....

gaudium® IVF Delivering Motherhood Dreams August 07,2026 BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers, Exchange Plaza, C-1, Block G, Dalal Street, Fort, Bandra Kurla Complex, Bandra (E), Mumbai — 400001, Maharashtra Mumbai — 400051, Maharashtra Scrip Code — 544709 Symbol - GAUDIUMIVF ISIN: INEOP8B01020 ISIN: INEOP8B01020 Dear Sir/Madam, Subject: Intimation for Board Meeting under Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("SEBI Listing Regulations'") Notice is hereby given pursuant to Regulation 29 and other applicable provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, that a meeting of the Board of Directors of Gaudium IVF and Women Health Limited (“Company”) is scheduled to be held on Thursday, August 13, 2026, to inter-alia, consider and approve the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter ended June 30, 2026 and to take on record the Auditor’s Limited Review Report thereon. The outcome of the Board meeting of the said results along with Auditor’s Limited Review Report issued by the Statutory Auditors of the Company will be submitted to you in accordance with SEBI Listing Regulations. Further, as communicated earlier in our letter dated June 26, 2026, pursuant to the provisions of Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, and as per the Company’s “Code of conduct to regulate, monitor and report trading by Designated Persons and their immediate relatives ("Code”) and Code of practices and procedures for fair disclosure of unpublished price sensitive information (“Fair Disclosure Code”), the trading window for dealing in the securities of the Company has been closed for the designated persons and their immediate relatives from Wednesday, July 01, 2026 and shall remain closed until 48 hours after the declaration of the aforesaid results. This disclosure will also be hosted on the website of the Company at https://www.gaudiumivfcentre.com. We request you to please take the same on record. Thanking You, Yours faithfully, For and on behaloff Gaudium IVF and Women Health Limited (Formerly known as Gaudium IVF and Women Health Private Limited) Naveen Kumar Company Secretary and Compliance Officer Membership No.: A69788 Gaudium IVF and Women Health Limited (Formerly known as Gaudium IVF and Women Health Pvt. Ltd.) Registered Office : B1/51, Janakpuri, New Delhi- 110058 | Ph: 011-4885 8585 CIN : L85100DL2015PLC278296 Email : info@gaudiumivfcentre.com Website : www.gaudiumivfcentre.com %